bluebird bio Inc (BLUE)
0.348
+0.05
(+16.82%)
USD |
NASDAQ |
Nov 22, 16:00
0.34
-0.01
(-2.30%)
After-Hours: 20:00
bluebird bio Total Assets (Quarterly): 465.06M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 465.06M |
| June 30, 2024 | 545.19M |
| March 31, 2024 | 631.48M |
| December 31, 2023 | 619.16M |
| September 30, 2023 | 613.61M |
| June 30, 2023 | 663.39M |
| March 31, 2023 | 692.74M |
| December 31, 2022 | 569.81M |
| September 30, 2022 | 520.10M |
| June 30, 2022 | 573.59M |
| March 31, 2022 | 491.07M |
| December 31, 2021 | 593.80M |
| September 30, 2021 | 1.340B |
| June 30, 2021 | 1.454B |
| March 31, 2021 | 1.637B |
| December 31, 2020 | 1.781B |
| September 30, 2020 | 1.945B |
| June 30, 2020 | 2.108B |
| March 31, 2020 | 1.529B |
| December 31, 2019 | 1.727B |
| September 30, 2019 | 1.892B |
| June 30, 2019 | 2.023B |
| March 31, 2019 | 2.139B |
| December 31, 2018 | 2.243B |
| Date | Value |
|---|---|
| September 30, 2018 | 2.352B |
| June 30, 2018 | 1.762B |
| March 31, 2018 | 1.867B |
| December 31, 2017 | 1.901B |
| September 30, 2017 | 1.406B |
| June 30, 2017 | 1.457B |
| March 31, 2017 | 1.073B |
| December 31, 2016 | 1.118B |
| September 30, 2016 | 918.26M |
| June 30, 2016 | 941.67M |
| March 31, 2016 | 978.70M |
| December 31, 2015 | 1.002B |
| September 30, 2015 | 1.018B |
| June 30, 2015 | 999.17M |
| March 31, 2015 | 533.82M |
| December 31, 2014 | 556.74M |
| September 30, 2014 | 330.19M |
| June 30, 2014 | 240.62M |
| March 31, 2014 | 209.51M |
| December 31, 2013 | 224.39M |
| September 30, 2013 | 228.26M |
| June 30, 2013 | 234.54M |
| March 31, 2013 | 137.46M |
| December 31, 2012 | 69.32M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
465.06M
Minimum
Sep 2024
2.108B
Maximum
Jun 2020
1.025B
Average
647.44M
Median
Total Assets (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 13.59M |
| Perspective Therapeutics Inc | 391.15M |
| Protalix BioTherapeutics Inc | 61.56M |
| Electromed Inc | 48.92M |
| Armata Pharmaceuticals Inc | 98.24M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 470.84M |
| Shareholders Equity (Quarterly) | -5.786M |
| Debt to Equity Ratio | -12.20 |
| Current Ratio | 0.5094 |
| Net Debt Paydown Yield | -14.02% |